Qingyou Xu

9PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersRegenerative medicine (incl. stem cells)Molecular medicineNon-Newtonian fluid flows (incl. rheology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Macrophage-Fibroblast Crosstalk in Kidney Injury: A Narrative Review.

|May 27, 2026
Esaxerenone Attenuates Aldosterone-Induced Renal Fibrosis by Suppressing Fibroblast-to-Lymphatic Endothelial-like Cell Transdifferentiation.

|Apr 17, 2025
Aldosterone-Induced Transformation of Vascular Smooth Muscle Cells into Macrophage-like Cells Participates in Inflammatory Vascular Lesions.

Boya Zhang, Ziqian Liu, Yi Chang

|Aug 29, 2024
Esaxerenone Attenuates Aldosterone-Induced Mitochondrial Damage-Mediated Pyroptosis in Mouse Aorta and Rat Vascular Smooth Muscle Cells.

Yunqian Xian, Xuan Wang, Yi Chang

|Jul 29, 2023
Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice.

Xiaomeng Gao, Jingyue Chang, Yi Chang

|Oct 03, 2022
Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.

Yi Chang, Ying Ben, Hui Li

Pageof 2

Frequent Collaborators

4 joint publications

Tatsuo Shimosawa

2 joint publications

Juan Hao

1 joint publications

Xuelian Ma

1 joint publications

Yi Chang